Jun 17, 2026 06:50AM
Jun 15, 2026 08:03AM
May 27, 2026 06:49AM
May 22, 2026 05:58AM
May 4, 2026 04:22PM
Apr 10, 2026 04:06PM
Apr 6, 2026 06:53AM H.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)
Mar 18, 2026 07:57AM
Mar 17, 2026 05:58PM
Mar 16, 2026 10:56AM
Jan 14, 2026 07:27AM
Jan 5, 2026 07:29AM
Nov 28, 2025 06:03AM
Nov 17, 2025 05:35AM BTIG Starts Alto Neuroscience (ANRO) at Buy
Nov 13, 2025 04:21AM
Nov 12, 2025 04:50PM
Oct 24, 2025 06:49AM
Oct 20, 2025 10:59AM
Oct 20, 2025 07:01AM
Sep 29, 2025 05:59AM
Sep 15, 2025 07:37AM H.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)
Sep 9, 2025 07:09AM
Aug 13, 2025 06:04PM
Jun 30, 2025 08:03AM
Jun 27, 2025 06:53AM
Jun 26, 2025 03:09PM
Jun 26, 2025 10:56AM
Jun 26, 2025 07:33AM Alto Neuroscience (ANRO) Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203
Jun 4, 2025 06:47AM
Jun 3, 2025 06:14AM
May 29, 2025 08:04AM
May 15, 2025 05:33PM
Feb 19, 2025 08:04AM
Feb 12, 2025 10:09AM
Feb 12, 2025 08:04AM Alto Neuroscience (ANRO) Announces Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial
Dec 16, 2024 07:04AM
Nov 13, 2024 04:46PM
Oct 23, 2024 06:44AM
Oct 23, 2024 06:24AM
Oct 22, 2024 04:44PM
Oct 22, 2024 04:30PM
Sep 10, 2024 08:25AM TD Cowen Reiterates Buy Rating on Alto Neuroscience (ANRO)
Sep 10, 2024 06:30AM
Sep 9, 2024 03:36PM
Sep 4, 2024 08:06AM
Sep 3, 2024 06:21AM
Jul 25, 2024 08:34AM
Jun 20, 2024 12:50PM

404,873 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All